News
Home>News & Events>Publications>D-RSC>The TREAT-NMD Advisory Committee for Therapeutics (TACT): An Innovative de-Risking Model to Foster Orphan Drug Development
144
Related Posts
-
226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
-
PPMD blogs about D-RSC Annual Meeting
-
Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
-
Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
-
D-RSC Definitions